Chemicals

Active Blanket Purchase Agreement Awarded Last action

Contract number
W81XWH22A0007
Awardee
Awarding agency
Task orders
6 $93,739 obligated

Award facts

Combined order value
$93,739 Current and potential, with all options
Last date to order 82% complete
IDV ceiling 6% used
$1,500,000.00
Maximum order
$250,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
PSC
6810 Chemicals
Set-aside
No set-aside
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The Defense Health Agency (DHA) awarded a single-award Blanket Purchase Agreement (BPA) contract worth up to $1,500,000 to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools located in Ann Arbor, Michigan. The BPA, which does not have a small business set-aside, is for the provision of chemicals, synthetic cannabinoids, and novel psychoactive substances to support the DHA's drug testing and medical supply needs through September 2027.

Under this BPA, the DHA has issued multiple firm fixed-price call orders to Cayman Chemical for the delivery of drug standards, screening and confirmation testing services, and medical supplies. The call orders, valued between $10,000 and $19,000, are in support of the DHA's programs to screen for suspected drug use in service member investigative and post-mortem samples, as well as to maintain readiness and provide health services within the military health system. Cayman Chemical's experience as a trusted federal supplier of critical research materials and its existing portfolio of government contracts and grants make it well-positioned to fulfill the DHA's requirements under this BPA.

Task orders

Task order Ordering agency Obligated Awarded
Drug standards to be used for screening and analysis testing of service member blood, urine and/or tissue samples. HT009025FG0910027 Defense Health Agency $30,366
Drug screening and ation testing for suspected drug use in service member investigative and/or post-mortem urine, blood… HT009025FG0210020 Defense Health Agency $11,273
Drug standards to be used for screening and ation testing of blood, urine and/or tissue samples HT009024FG0910025 Defense Health Agency $18,891
Drug standards to be used for drug screening and ation testing of servicemember specimens HT009024FG0810027 Defense Health Agency $11,540
Standards will be used for screening and ation of suspected drug use in service member and/or post-mortem urine… HT009023FG0510015 Defense Health Agency $10,788
Medical supplies HT009023FG0310015 Defense Health Agency $10,880

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · Synthetic cannabinoids and novel psychoactive substances $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 · Per section 711 of the NAT. DEF. Auth. Act of 2019, the U.S. Army medical research acquisition activity, and U.S. Army medical research & development command… $0
Original award $0

Quick answers

Who was awarded contract W81XWH22A0007?

W81XWH22A0007 was awarded to Cayman Chemical Co Inc. by Defense Health Agency (Department of Defense) on September 1, 2022.

How much is contract W81XWH22A0007 worth?

Orders under W81XWH22A0007 have obligated $93,739. W81XWH22A0007's own ceiling is $1,500,000. A single order can be worth up to $250,000.

How many orders have been placed under contract W81XWH22A0007?

6 orders have been placed under W81XWH22A0007, the latest on August 19, 2025.

Who can order from contract W81XWH22A0007?

W81XWH22A0007 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login